Reply to an Answer

In response to:

Cimzia is a biologic drug, recently approved to treat moderate to severe Crohn's disease in adults. Like other similar biologics, such as Remicade and Humira, it blocks tumor necrosis factor (TNF), which is thought to play an important role in the inflammation related to Crohn's disease. The active ingrediant in Cimzia is certolizumab pegol. Patient information from the manufacturer, UCB, is available at: http://www.cimzia.com/Default1.asp For information about assistance with insurance co-pays (which will vary from policy to policy): http://www.cimzia.com/cimplicity2.asp

Subject:

Comment:

Display Name:

Note: This Display Name will be publicly visible on your SharePosts, your profile on this site, and the rest of the Internet. To maintain your anonymity do not include personally identifiable information (such as your name or email address) in your Display Name, SharePosts, or any other public postings on our site.

Role:

Email Address:

Password:

Confirm password:

Type the letters shown in the box to the right:

Accept Our Terms of Service

Please send me news updates, top features and
highlights via the MyIBDCentral.com newsletter.
View sample.

Email:

Password:

Remember Me:

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyIBDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyIBDCentral.com

Reply to an Answer